Activation of JNK and high expression level of CD133 predict a poor response to sorafenib in hepatocellular carcinoma
Satoru Hagiwara(Kindai University Hospital), Toshiharu Sakurai(Kindai University)
Cited by 106
Related Papers
Cold‐inducible <scp>RNA</scp>‐binding protein promotes the development of liver cancer
|Cancer Science|2015|60
A New Prognostic Staging System for Hepatocellular Carcinoma: Value of the Biomarker Combined Japan Integrated Staging Score
|Intervirology|2008|42
Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma
|Melanoma Research|2017|29
Contribution of C1485T mutation in the HBx gene to human and murine hepatocarcinogenesis
|Scientific Reports|2017|5